vimarsana.com

Page 20 - டெக்சாஸ் ஆரோக்கியம் அறிவியல் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IGM Biosciences Announces the Appointment of Chris H Takimoto, M D , Ph D , F A C P , as Chief Medical Officer

IGM Biosciences Announces the Appointment of Chris H. Takimoto, M.D., Ph.D., F.A.C.P., as Chief Medical Officer MOUNTAIN VIEW, Calif., July 29, 2021 (GLOBE NEWSWIRE) IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced the appointment of Chris H. Takimoto, M.D., Ph.D., F.A.C.P., to the role of Chief Medical Officer, effective today. Dr. Takimoto will be responsible for global development of IGM’s clinical pipeline of proprietary IgM antibodies. He joins IGM with 30 years of experience in cancer research and development, most recently as Senior Vice President, Oncology, Gilead Sciences, Inc. Daniel S. Chen, M.D., Ph.D., will continue to assist the Company in a consulting capacity.

New evidence has doctors worried about long-term damage from COVID brain fog

New evidence has doctors worried about long-term damage from COVID brain fog • 5 min read How to clear up ‘brain fog’ Dr. Kristen Willeumier gives tips on how to improve brain function and overall health while dealing with the challenges of working from home and being confined inside. Phill Magakoe/Pool via Reuters/FILE A flurry of new scientific findings is prompting renewed concern among doctors about the long-term cognitive impacts of COVID-19 in some patients. Several new studies presented at the Alzheimer s Association International Conference, being held this week in Denver, have found that many COVID-19 patients experience brain fog and other cognitive impairments months after recovery. This adds to a growing body of research on COVID-19 s apparent long-haul symptoms, which can include confusion, forgetfulness and other worrying signs of memory loss.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.